Food marketing terms are one tool to help you make healthy choices. But some of them are just that – marketing. They can be terms that don’t signal any true health benefit. Our expert unpacks the truth behind some common “healthy” labels.
The Investor Relations website contains information about Exelixis, Inc.’s business for stockholders, potential investors, and financial analysts.
Cagrilintide and semaglutide have each been shown to induce weight loss as monotherapies. Data are needed on the coadministration of cagrilintide and semaglutide (called CagriSema)…
Cagrilintide and semaglutide have each been shown to induce weight loss as monotherapies. Data are needed on the coadministration of cagrilintide and semaglutide (called CagriSema)…
Cagrilintide and semaglutide have each been shown to induce weight loss as monotherapies. Data are needed on the coadministration of cagrilintide and semaglutide (called CagriSema)…
PURPOSEAcral lentiginous melanoma is a subtype of cutaneous melanoma arising from palmar, plantar, or subungual skin. These tumors are characterized by aggressive biology, a low…
PURPOSETo assess the impact and outcomes of a novel program for routine preemptive DPYD testing in fluoropyrimidine (FP)-naïve patients.PATIENTS AND METHODSThis single-center, retrospective cohort study…
In the current evolving landscape of cancer treatment, the notion that all patients with advanced cancer, but especially those with rare cancers, must receive comprehensive…
Universal germline and tumor genomic testing needed to win the war against cancer.
This Viewpoint argues for universal tumor sequencing.
The field of rare cancer research is rapidly transforming, marked by significant progress in clinical trials and treatment strategies. Rare cancers, as defined by the…
